Capricor Therapeutics
CAPR
NASDAQ
IPO2002
about CAPR
Capricor Therapeutics specializes in developing innovative therapies for rare diseases and neurodegenerative conditions through cutting-edge cell-based and gene therapy methods.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $33.00 | $33.00 | $29.41 | $1.7B | 2.61M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.54 | n/a | n/a | 0% | 0% | 0% |